000 01532 a2200457 4500
005 20250514181433.0
264 0 _c20040525
008 200405s 0 0 eng d
022 _a0340-5354
024 7 _a10.1007/s00415-004-0286-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHarkness, K A
245 0 0 _aMetastatic malignant melanoma presenting as a cavernous sinus syndrome.
_h[electronic resource]
260 _bJournal of neurology
_cFeb 2004
300 _a224-5 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAdult
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aBiomarkers, Tumor
650 0 4 _aBlepharoptosis
_xetiology
650 0 4 _aCavernous Sinus Thrombosis
_xetiology
650 0 4 _aCranial Nerves
_xpathology
650 0 4 _aDacarbazine
_xanalogs & derivatives
650 0 4 _aFatal Outcome
650 0 4 _aHeadache
_xetiology
650 0 4 _aHumans
650 0 4 _aLymph Nodes
_xpathology
650 0 4 _aMagnetic Resonance Imaging
650 0 4 _aMale
650 0 4 _aMelanoma
_xradiotherapy
650 0 4 _aNeoplasm Metastasis
_xpathology
650 0 4 _aOphthalmoplegia
_xetiology
650 0 4 _aOrbital Neoplasms
_xradiotherapy
650 0 4 _aRisk Factors
650 0 4 _aSkin Neoplasms
_xpathology
650 0 4 _aSurvival Rate
650 0 4 _aTemozolomide
700 1 _aManford, M R A
773 0 _tJournal of neurology
_gvol. 251
_gno. 2
_gp. 224-5
856 4 0 _uhttps://doi.org/10.1007/s00415-004-0286-6
_zAvailable from publisher's website
999 _c14712078
_d14712078